| Institute |
|---|
| Moravian Biotechnology |
| SKU: | 160768 |
|---|---|
| Product description: | AHSA1 (Activator Of HSP90 ATPase Activity 1) is a Protein Coding gene. Diseases associated with AHSA1 include Stomatitis and Cystic Fibrosis. Among its related pathways are T cell receptor signaling pathway and Mechanisms of CFTR activation by S-nitrosoglutathione (normal and CF). |
| Alternate name: | Activator of 9 kDa heat shock protein ATPase homolog 1 |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | O95433 |
| Immunogen Uniprot ID: | O95433 |
| Cat. #: | 160768 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Cell signaling and signal transduction |
| Application: | WB ; IHC |
| Target: | AHSA1 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | AHSA1 (Activator Of HSP90 ATPase Activity 1) is a Protein Coding gene. Diseases associated with AHSA1 include Stomatitis and Cystic Fibrosis. Among its related pathways are T cell receptor signaling pathway and Mechanisms of CFTR activation by S-nitrosoglutathione (normal and CF). |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.